A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0.360. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →California Institute for Regenerative Medicine
Grant: DISC2COVID19-12022
HHS | NIH | National Cancer Institute
Grant: 3R01CA207189-05S1
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI036214
NHLBI NIH HHS
Grant: R01 HL154926
NIAID NIH HHS
Grant: P30 AI036214
NIA NIH HHS
Grant: R01 AG063925
NHLBI NIH HHS
Grant: R01 HL166485
NIH HHS
Grant: S10 OD026929
NCI NIH HHS
Grant: R01 CA207189
NHLBI NIH HHS
Grant: R01 HL148436
NHLBI NIH HHS
Grant: T32 HL166127
NHLBI NIH HHS
Grant: R01 HL157985
FWCI
2.80
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals